PT792287E - Analogos peptidicos da proteina basica da mielina humana - Google Patents
Analogos peptidicos da proteina basica da mielina humanaInfo
- Publication number
- PT792287E PT792287E PT95942843T PT95942843T PT792287E PT 792287 E PT792287 E PT 792287E PT 95942843 T PT95942843 T PT 95942843T PT 95942843 T PT95942843 T PT 95942843T PT 792287 E PT792287 E PT 792287E
- Authority
- PT
- Portugal
- Prior art keywords
- analogs
- basic protein
- myelin basic
- human myelin
- peptidical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/342,408 US6329499B1 (en) | 1994-11-18 | 1994-11-18 | Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein |
Publications (1)
Publication Number | Publication Date |
---|---|
PT792287E true PT792287E (pt) | 2004-09-30 |
Family
ID=23341698
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT95942843T PT792287E (pt) | 1994-11-18 | 1995-11-16 | Analogos peptidicos da proteina basica da mielina humana |
Country Status (13)
Country | Link |
---|---|
US (2) | US6329499B1 (pt) |
EP (2) | EP0792287B1 (pt) |
JP (1) | JPH10509172A (pt) |
AT (1) | ATE266043T1 (pt) |
AU (1) | AU4405896A (pt) |
CA (1) | CA2204147A1 (pt) |
DE (1) | DE69532996T2 (pt) |
DK (1) | DK0792287T3 (pt) |
ES (1) | ES2218559T3 (pt) |
MX (1) | MX9703643A (pt) |
NO (1) | NO972264L (pt) |
PT (1) | PT792287E (pt) |
WO (1) | WO1996016086A1 (pt) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6252040B1 (en) | 1991-10-22 | 2001-06-26 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
WO1996012737A2 (en) * | 1994-10-25 | 1996-05-02 | Immulogic Pharmaceutical Corporation | Compositions and treatment for multiple sclerosis |
US6329499B1 (en) | 1994-11-18 | 2001-12-11 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein |
US6251396B1 (en) | 1994-11-18 | 2001-06-26 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
CA2205532A1 (en) * | 1994-11-18 | 1996-05-30 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein |
US6379670B1 (en) | 1994-11-18 | 2002-04-30 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
US5874531A (en) * | 1995-03-07 | 1999-02-23 | President And Fellows Of Harvard College | Identification of self and non-self antigens implicated autoimmune disease |
WO1996028470A2 (en) * | 1995-03-09 | 1996-09-19 | Neurocrine Biosciences, Inc. | Peptide analogues of human myelin basic protein useful in treating multiple sclerosis |
US6737057B1 (en) | 1997-01-07 | 2004-05-18 | The University Of Tennessee Research Corporation | Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
CA2494338C (en) * | 1997-04-04 | 2007-07-17 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
CN102784385B (zh) | 2000-08-21 | 2015-11-25 | 阿皮托普技术(布里斯托尔)有限公司 | 肽选择方法 |
MXPA03010037A (es) * | 2001-05-01 | 2004-06-30 | Univ California | Moleculas de fusion y metodos para tratamiento de enfermedades inmunes. |
US7265208B2 (en) | 2001-05-01 | 2007-09-04 | The Regents Of The University Of California | Fusion molecules and treatment of IgE-mediated allergic diseases |
WO2004032824A2 (en) | 2002-10-10 | 2004-04-22 | Yeda Research And Development Co. Ltd. | Basic esters of fatty alcohols and their use as anti-inflammatory or immunomodulatory agents |
US7084247B2 (en) * | 2004-03-11 | 2006-08-01 | Peptimmune, Inc. | Identification of self and non-self antigens implicated in autoimmune diseases |
WO2006019982A2 (en) * | 2004-07-15 | 2006-02-23 | Vernalis Plc | Pin1-modulating compounds and methods of use thereof |
US20060240032A1 (en) * | 2005-03-31 | 2006-10-26 | Hinrichs David J | Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases |
CA2632630C (en) | 2005-12-13 | 2016-12-06 | President And Fellows Of Harvard College | Scaffolds for cell transplantation |
US9770535B2 (en) | 2007-06-21 | 2017-09-26 | President And Fellows Of Harvard College | Scaffolds for cell collection or elimination |
US9370558B2 (en) | 2008-02-13 | 2016-06-21 | President And Fellows Of Harvard College | Controlled delivery of TLR agonists in structural polymeric devices |
JP5690143B2 (ja) | 2008-02-13 | 2015-03-25 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 持続的細胞プログラミング装置 |
US9012399B2 (en) | 2008-05-30 | 2015-04-21 | President And Fellows Of Harvard College | Controlled release of growth factors and signaling molecules for promoting angiogenesis |
US9297005B2 (en) | 2009-04-13 | 2016-03-29 | President And Fellows Of Harvard College | Harnessing cell dynamics to engineer materials |
WO2011014871A1 (en) * | 2009-07-31 | 2011-02-03 | President And Fellows Of Harvard College | Programming of cells for tolerogenic therapies |
WO2011109834A2 (en) | 2010-03-05 | 2011-09-09 | President And Fellows Of Harvard College | Enhancement of skeletal muscle stem cell engrafment by dual delivery of vegf and igf-1 |
US9693954B2 (en) | 2010-06-25 | 2017-07-04 | President And Fellows Of Harvard College | Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones |
LT2624873T (lt) | 2010-10-06 | 2020-03-10 | President And Fellows Of Harvard College | Įšvirkščiami, poras sudarantys hidrogeliai, skirti medžiagų pagrindo ląstelių terapijai |
US9603894B2 (en) | 2010-11-08 | 2017-03-28 | President And Fellows Of Harvard College | Materials presenting notch signaling molecules to control cell behavior |
US10647959B2 (en) | 2011-04-27 | 2020-05-12 | President And Fellows Of Harvard College | Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation |
CA2833385C (en) | 2011-04-28 | 2020-10-27 | President And Fellows Of Harvard College | Injectable preformed macroscopic 3-dimensional scaffolds for minimally invasive administration |
US9675561B2 (en) | 2011-04-28 | 2017-06-13 | President And Fellows Of Harvard College | Injectable cryogel vaccine devices and methods of use thereof |
AU2012261848B2 (en) | 2011-06-03 | 2017-06-15 | President And Fellows Of Harvard College | In situ antigen-generating cancer vaccine |
ES2773895T3 (es) | 2012-04-16 | 2020-07-15 | Harvard College | Composiciones de sílice mesoporosa para modular las respuestas inmunitarias |
WO2015168379A2 (en) | 2014-04-30 | 2015-11-05 | President And Fellows Of Harvard College | Combination vaccine devices and methods of killing cancer cells |
CA3012602A1 (en) | 2015-01-30 | 2016-08-04 | President And Fellows Of Harvard College | Peritumoral and intratumoral materials for cancer therapy |
JP7094533B2 (ja) | 2015-04-10 | 2022-07-04 | プレジデント アンド フェローズ オブ ハーバード カレッジ | 免疫細胞捕捉デバイスおよびその製造および使用方法 |
WO2017136837A1 (en) | 2016-02-06 | 2017-08-10 | President And Fellows Of Harvard College | Recapitulating the hematopoietic niche to reconstitute immunity |
WO2018013797A1 (en) | 2016-07-13 | 2018-01-18 | President And Fellows Of Harvard College | Antigen-presenting cell-mimetic scaffolds and methods for making and using the same |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1340012C (en) | 1987-08-17 | 1998-08-25 | Trustees Of Leland Stanford Jr. University | Peptide determinant associated with immunity |
US5468481A (en) * | 1988-06-23 | 1995-11-21 | Amergen, Inc. | MHC class II-peptide conjugates useful in ameliorating autoimmunity |
GB8915019D0 (en) * | 1989-06-30 | 1989-08-23 | Matthews Ruth C | Medicaments |
DE69127470T2 (de) | 1990-03-02 | 1998-02-19 | Autoimmune Inc | Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen |
US6077509A (en) | 1990-03-30 | 2000-06-20 | Autoimmune, Inc. | Peptide fragments of myelin basic protein |
ATE189230T1 (de) | 1991-05-31 | 2000-02-15 | Connetics Corp | T-zell rezeptorpeptide als therapeutika für immun-verwandte krankheiten |
CA2053799C (en) | 1991-10-22 | 2002-03-12 | Kenneth G. Warren | Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid |
US5817629A (en) | 1991-10-22 | 1998-10-06 | The Governors Of The University Of Alberta | Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
BR9306272A (pt) | 1992-04-09 | 1998-06-23 | Autoimmune Inc | Peptídeo e composiçao farmacêutica |
JPH06157591A (ja) * | 1992-11-27 | 1994-06-03 | Teijin Ltd | 抗凝固性ペプチド |
US5559209A (en) * | 1993-02-18 | 1996-09-24 | The General Hospital Corporation | Regulator regions of G proteins |
JPH09502981A (ja) | 1993-09-22 | 1997-03-25 | ザ ボード オブ トラスティーズ フォー ザ リーランド スタンフォード ジュニア ユニバーシティ | 自己免疫疾患におけるt−細胞レセプターと抗原の相互作用 |
US6329499B1 (en) | 1994-11-18 | 2001-12-11 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein |
CA2205532A1 (en) | 1994-11-18 | 1996-05-30 | Neurocrine Biosciences, Inc. | Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein |
WO1996028470A2 (en) | 1995-03-09 | 1996-09-19 | Neurocrine Biosciences, Inc. | Peptide analogues of human myelin basic protein useful in treating multiple sclerosis |
-
1994
- 1994-11-18 US US08/342,408 patent/US6329499B1/en not_active Expired - Fee Related
-
1995
- 1995-11-16 EP EP95942843A patent/EP0792287B1/en not_active Expired - Lifetime
- 1995-11-16 CA CA002204147A patent/CA2204147A1/en not_active Abandoned
- 1995-11-16 WO PCT/US1995/014403 patent/WO1996016086A1/en active IP Right Grant
- 1995-11-16 EP EP03028981A patent/EP1440980A3/en not_active Withdrawn
- 1995-11-16 DK DK95942843T patent/DK0792287T3/da active
- 1995-11-16 ES ES95942843T patent/ES2218559T3/es not_active Expired - Lifetime
- 1995-11-16 PT PT95942843T patent/PT792287E/pt unknown
- 1995-11-16 MX MX9703643A patent/MX9703643A/es unknown
- 1995-11-16 AU AU44058/96A patent/AU4405896A/en not_active Abandoned
- 1995-11-16 DE DE69532996T patent/DE69532996T2/de not_active Expired - Fee Related
- 1995-11-16 AT AT95942843T patent/ATE266043T1/de not_active IP Right Cessation
- 1995-11-16 JP JP8516911A patent/JPH10509172A/ja active Pending
-
1997
- 1997-05-16 NO NO972264A patent/NO972264L/no unknown
-
2001
- 2001-12-11 US US10/015,540 patent/US20020086976A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1440980A2 (en) | 2004-07-28 |
EP0792287B1 (en) | 2004-05-06 |
ES2218559T3 (es) | 2004-11-16 |
DK0792287T3 (da) | 2004-08-30 |
US20020086976A1 (en) | 2002-07-04 |
EP0792287A1 (en) | 1997-09-03 |
NO972264L (no) | 1997-07-16 |
WO1996016086A1 (en) | 1996-05-30 |
MX9703643A (es) | 1997-08-30 |
DE69532996T2 (de) | 2005-04-14 |
US6329499B1 (en) | 2001-12-11 |
EP1440980A3 (en) | 2005-01-19 |
JPH10509172A (ja) | 1998-09-08 |
ATE266043T1 (de) | 2004-05-15 |
AU4405896A (en) | 1996-06-17 |
NO972264D0 (no) | 1997-05-16 |
DE69532996D1 (de) | 2004-06-09 |
CA2204147A1 (en) | 1996-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT792287E (pt) | Analogos peptidicos da proteina basica da mielina humana | |
AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
ATE108662T1 (de) | Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus. | |
PT662827E (pt) | Metodos de diagnostico e composicoes farmaceuticas a base de proteinas notch e acidos nucleicos | |
WO1996028470A3 (en) | Peptide analogues of human myelin basic protein useful in treating multiple sclerosis | |
DE69525544D1 (de) | Peptidanaloge des menschlichen, basischen myelinproteins mit substitution an position 91 zur behandlung der multiplen sklerose | |
DE69627704D1 (en) | Protegrine | |
ES2168354T3 (es) | Protegrinas. | |
ES2076999T3 (es) | Peptidos anticoagulantes radiomarcados. | |
BR9306272A (pt) | Peptídeo e composiçao farmacêutica | |
DK384084A (da) | Vaeksthormonfrigoerende peptider samt fremgangsmaade til behandling af pattedyr hermed | |
ATE223481T1 (de) | Peptid der löslichen form von acetylcholinesterase mit aktivität als calciumkanalmodulator | |
DK525384D0 (da) | Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat | |
MX9203175A (es) | Composicion de implante que contiene un peptido, polipeptido o proteina biologicamente activa y procedimiento para su preparacion. | |
ATE323724T1 (de) | Mpl-liganden analoga | |
NZ235497A (en) | Peptides (possibly related to hirudin) and pharmaceutical compositions for reducing blood coagulation | |
ATE42308T1 (de) | Pharmakologisch aktive peptide. | |
ES2142840T3 (es) | Proteina que se une al interferon alfa/beta, su preparacion y las composiciones farmaceuticas que la contienen. | |
DE69032574D1 (de) | Antibakterielle- und antimalariapeptide | |
ATE27822T1 (de) | Hexapeptid, verfahren zur herstellung und pharmazeutische zusammensetzungen hieraus. |